One page, thousands of outlets. See who else covered it.
Trump's new tariffs on about $20 billion worth of Canadian goods were set to take effect Wednesday, but were postponed by three days.
We haven't written up this one. CNBC has the full story — the link below goes straight to it.
This is one outlet's version. Read the fullest account.
Injective says the registration gives it a regulated way to keep track of who owns tokenized securities and how those assets change hands.
Growth in Pro, home services and online sales helped the home improvement retailer eke out a 0.2% comp increase.
A record surge in Moderna Inc.’s shares delivered a $5 billion blow to short sellers who had bet that the vaccine maker’s years-long slump would continue.
CNBC Pro screened the S&P 1500 to list stocks that will benefit most if yields pullback
PodcastOne revenue hit record $16.1 million as management pursues $400 million in M&A deals.
Moderna shares more than doubled and set an intraday record while Merck climbed more than 10 per cent Wednesday, though questions remain
